Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 281 participants.

Also called NCT06415214

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 281 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06415214
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06415214. Randomized; quadruple masking; primary purpose treatment. Start 2024-06-21 (actual); primary completion 2025-07-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes
Acronym
SOLID-DKD
Condition
Diabetic Kidney Disease, Type 2 Diabetes
Intervention (Drug)
Placebo
Intervention (Drug)
HRS-7535
Lead sponsor
Shandong Suncadia Medicine Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct06415214
Content hash
b524dde14bd5580dded641fd3f31be8ad26bda663f3b6d8520396a264f3cabef